The Valley Desk

ArticleMolecular oncologyPublished

A novel pipeline for prioritizing cancer type-specific therapeutic vulnerabilities using DepMap identifies PAK2 as a target in head and neck squamous cell carcinomas

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name University of Pennsylvania, The Wistar Institute. Affiliation source

Publication record

Type
Article
Venue
Molecular oncology
Published
Subject terms
Cell Line, Tumor; Humans; Head and Neck Neoplasms; p21-Activated Kinases; Squamous Cell Carcinoma of Head and Neck; Protein Serine-Threonine Kinases; Targeted Therapy; Head And Neck Squamous Cell Carcinoma; Crispr; Pak2; Wild Type P53; Depmap
PubMed ID
37997254
PubMed Central ID
PMC10850805
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal